Morita T
Department of Pathology, Nippon Medical School, Japan.
Nihon Ika Daigaku Zasshi. 1990 Oct;57(5):384-96. doi: 10.1272/jnms1923.57.384.
Hepatocellular carcinoma (HCC) with or without cirrhosis in autopsy cases were compared clinically and pathologically. Seventy-five patients with HCC were autopsy cases: 51 had cirrhosis and 24 did not. The patients had been admitted between 1976 and 1986 and were studied in regard to age, sex, clinical onset, past history of hepatic disease, concomitant illness, etiologic factors (HB virus, blood transfusion and alcoholic history), cause of death, extrahepatic metastasis, time span between onset and death, size of the liver and spleen, mode of metastasis, tumor size, degree of anaplasia and also cancer cell histology, metastasis in patients who had received a transhepatic arterial embolization (TAE). Differences were found between the cirrhotic and non-cirrhotic groups with respect to past history of hepatic disease, history of alcoholic abuse and cause of death. Notably in non-cirrhotic HCC, death was due to infection in many cases. Additionally extrahepatic metastasis was compared with respect to tumor type and degree of anaplasia. The incidence of metastasis was over 5 cm in solitary nodule cases. Patients with hematogenous metastasis alone were found in many cases to have multiple nodule type tumors in both the cirrhotic and non-cirrhotic groups. The rate of extrahepatic metastasis was high in patients with anaplasia III and IV in both groups, but the incidence of hematogenous metastasis was particularly high in anaplasia I and II in HCC with cirrhosis. Cancer cell histology was not correlated with extrahepatic metastasis. All the patients treated with TAE were shown to have metastasis in the autopsy. However, the patterns of metastasis in these patients were similar to those in patients who did not receive TAE.
对尸检病例中伴有或不伴有肝硬化的肝细胞癌(HCC)进行了临床和病理比较。75例HCC患者为尸检病例:51例有肝硬化,24例无肝硬化。这些患者于1976年至1986年入院,研究内容包括年龄、性别、临床发病情况、既往肝脏疾病史、伴随疾病、病因(乙肝病毒、输血及酗酒史)、死亡原因、肝外转移情况、发病至死亡的时间跨度、肝脏和脾脏大小、转移方式、肿瘤大小、间变程度以及癌细胞组织学类型,还包括接受经肝动脉栓塞术(TAE)患者的转移情况。在肝脏疾病既往史、酗酒史和死亡原因方面,肝硬化组和非肝硬化组之间存在差异。值得注意的是,在非肝硬化性HCC中,许多病例的死亡原因是感染。此外,还比较了肝外转移与肿瘤类型和间变程度的关系。孤立结节病例中转移发生率超过5厘米。在肝硬化组和非肝硬化组中,许多单纯血行转移的患者都有多发结节型肿瘤。两组间变Ⅲ级和Ⅳ级患者的肝外转移率较高,但在伴有肝硬化的HCC中,间变Ⅰ级和Ⅱ级患者的血行转移发生率尤其高。癌细胞组织学类型与肝外转移无关。所有接受TAE治疗的患者在尸检中均显示有转移。然而,这些患者的转移模式与未接受TAE治疗的患者相似。